SOCRA CCRP Practice Exam

A Providing an explanation within a year is not an appropriate response to a Warning Letter from the FDA as it requires a prompt and timely response.

B: Ignoring the letter until a second notice is not a suitable response as it could result in further action from the FDA, leading to potential consequences for the facility.

D: Requesting a dismissal of the letter is not a recommended response as it does not address the issues raised by the FDA and may be seen as evasive or non-compliant. It is important for the facility to respond to the letter promptly and address any concerns raised by the FDA. Therefore, option C is the correct response as it demonstrates a proactive and compliant approach to the Warning Letter.